Italy· 049274020
LEQVIO*1 siringa preriempita SC 1,5 ml 284 mg 189 mg/ml con dispositivo di protezione dell'ago
A inclisiran product containing inclisiran, registered in Italy by NOVARTIS EUROPHARM LTD, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Inclisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AX16 (inclisiran), each read from that country’s own register.
- This record: Italy
- 9 of them publish a price we can compare per daily dose
Inclisiran · ATC C10AX16
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Active substance
- Inclisiran
- Manufacturer
- NOVARTIS EUROPHARM LTD
- Country
- Italy (IT)
- ATC code
- C10AX16
- ATC class
- Inclisiran
- Defined daily dose
- 1.6 mg, P
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic049274020LEQVIO*1 siringa preriempita SC 1,5 ml 284 mg 189 mg/ml con dispositivo di protezione dell'agoEUR 4205.49
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inclisiran in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainLEQVIO 284 mg SOLUCION INYECTABLE EN JERINGA PRECARGADANovartis Europharm Limited
- NorwayLeqvioOrifarm AS
- IrelandLeqvio 284 mg solution for injection in pre-filled syringeNovartis Europharm Limited
- IcelandLeqvioNovartis Europharm Limited*
- NetherlandsLeqvio 284 mg oplossing voor injectie in een voorgevulde spuitNovartis Europharm Limited
- PolandLeqvioNovartis Europharm Limited
- CanadaLEQVIONOVARTIS PHARMACEUTICALS CANADA INC
- SwedenLeqvio 284 mg Injektionsvätska, lösning i förfylld sprutaNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Leqvio
- Liechtenstein · Leqvio
- Norway · Leqvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b3ccea4-6322-43b9-97bd-e36305dc428f GET /v1/drugs/8b3ccea4-6322-43b9-97bd-e36305dc428f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4205.49,
"source": "aifa",
"currency": "EUR",
"strength": "INCLISIRAN 284MG 1,5ML SOLUZIONE USO PARENTERALE",
"substance": "Inclisiran",
"equivalence_group": "LSO",
"transparency_flag": null
}See everything about inclisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.